A Single-Center Review of the Outcomes and Safety of Renal Biopsy in Pregnancy
DOI:
https://doi.org/10.26719/LJMR.18.2.04Keywords:
Pregnancy, glomerulonephritis, pre-eclampsia, hypertensionAbstract
Purpose: Renal disease is rare in pregnancy but presents a clinical dilemma with the safety profile of kidney biopsies
during pregnancy unclear. Current guidelines have no consensus on the indication and timing, or criteria for selecting
patients on, whom the benefits of a renal biopsy during pregnancy outweigh the risks of performing a safe renal biopsy.
The aims of our research study were to determine the impact and safety of renal biopsy in the management of pregnant
patients with renal diseases at Tygerberg Hospital from 1990 to 2019.
Methods: A series of percutaneous renal biopsies performed in 21 pregnant women with renal disease presenting during
pregnancy over the past 30 years (1990–2019) were reviewed. Indications, timing, post-biopsy complications,
histopathologic findings, management, and maternal and fetal outcome were reviewed for each case.
Results: The main indication for renal biopsy was suspected of glomerular diseases (81%). The median gestational age at
the time of biopsy was fifteen weeks and six days in the range of 2-32 weeks. No patient developed any bleeding post
renal biopsy (hematuria, subcapsular renal bleed , retroperitoneal bleed) . Most of the women had a glomerular disorder on
renal biopsy, with mesangiocapillary glomerulonephritis (MCGN) being the most common histological diagnosis (23.8%).
Six patients required conservative treatment only, while 14 patients required additional steroids, and only one patient
required both steroids and an immunosuppressive agent. Out of 21 women patients, 14 (66.7%) had developed chronic
kidney disease, while seven (33.3%) patients had normal kidney function. Eleven (52.5%) of the pregnant women had a
normal delivery, while seven (33.3%) had a termination of pregnancy (MTOR), two premature deliveries after 33 weeks
to save the kidneys during delivery, and one miscarriage .
Conclusions: A renal biopsy performed during pregnancy is not contraindicated, and pregnancy didn’t lead to an
increased risk of biopsy bleeding in our study, Results of histopathological studies are useful to and, in advising
continuation or termination of pregnancy, recommend specific therapeutic modalities.
Downloads
References
Smith MC, Moran P, Ward MK, Davison JM. Assessment of glomerular filtration rate during pregnancy using the MDRD formula. Br J Obstet Gynaecol. 2008; 115:109-112.
Kattah A, Milic N, White W, Garovic V. Spot urine protein measurements in normotensive pregnancies, pregnancies with isolated proteinuria and preeclampsia. AmJ Physiol Regul Integr Comp Physiol. 2017;313(4):418-424.
Odutayo A, Hladunewich M. Obstetric nephrology: renal hemodynamic and metabolic physiology in normal pregnancy. Clin J AmSoc Nephrol. 2012;7(12):2073-2080.
Davison J, Lindheimer M. Pregnancy and chronic kidney disease. Semin Nephrol 2011; 31:86–
Khanna R. Clinical Presentation & Management of Glomerular Diseases: Hematuria, Nephritic & Nephrotic Syndrome. Mo Med. 2011;108(1):33-36.
Rachael James P and Catherine Nelson-Piercy. Management of hypertension before, during, and after pregnancy. Heart. 2004; 90(12):1499-1504.
Mayrink J, Costa ML, Cecatti JG. Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction. Scientific World Journal. 2018;6.
Bajwa S, Kwatra I, Bajwa S, Kaur M. Renal diseases during pregnancy: Critical and current perspectives. Journal of obstetric anaesthesia and critical care. 2013;3(1):7-15.
Wearne N. Pregnancy and the kidneys. Continuing Medical Education. 2014; 104(9):642.
Kapoor N, Makanjuola D, Shehata H. Review Management of women with chronic renal disease in pregnancy. The Obstetrician & Gynaecologist. 2009; 11:185-191.
Michelle A. Hladunewich, Kate Bramham, Belinda Jim and Sharon Maynard. Managing glomerular disease in pregnancy. Nephrol Dial Transplant. 2017; 32:48-56.
Packham D, Fairley KF. Renal biopsy: indications and complications in pregnancy. Br J Obstet Gynaecol. 1987; 94:935-939.
Lindheimer MD, Davison JM. Renal biopsy during pregnancy: “To b… or not to b…?”. Br J Obstet Gynaecol. 1987; 94:932-934.
Kuller JA, D’Andrea NM, McMahon MJ. Renal biopsy and pregnancy. Am J Obstet Gynecol. 2001; 184:1093-1096.
Chen HH, Lin HC, Yeh JC, Chen CP. Renal biopsy in pregnancies complicated by undetermined renal disease. Acta Obstet Gynecol Scand.2001; 80:888-893.
Day C, Hewins P, Hildebrand S, Sheikh L, Taylor G, Kilby M, et al. The role of renal biopsy in women with kidney disease identified in pregnancy. Nephrol Dial Transplant 2008; 23:201-206.
Day C, Hewins P, Hildebrand S, Sheikh L, Taylor G, Kilby M, et al. The role of renal biopsy in women with kidney disease identified in pregnancy. Nephrol Dial Transplant 2008; 23:201-206.
Schewitz LJ, Friedman IA and Pollak VE. Bleeding after renal biopsy in pregnancy. Obstet Gynecol. 1965; 26:295-304.
McCartney C. P. Pathological anatomy of acute hypertension of pregnancy. 1964. Circulation 30, suppl. 2, 37-42.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Salah M Bashir, John Nel, William Bates (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
